The outcome indicated that S100A8 expression levels were significantly higher in four metabolic related diseases, namely obesity, diabetes, hypertension and hyperlipidaemia, than in the control group (Figures 10A–D). The gene discussed is S100A8; the disease is hyperlipidemia.